Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -8 of 8
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
11/8/2007
 
First Published:
6/1/2000
1.
Phase III Randomized Study of Whole Brain Radiotherapy With or Without RSR13 in Patients With Brain Metastases
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Completed
18 and over
Pharmaceutical / Industry
ALLOS-RSR13RT-009
NCT00005887
Last Modified:
8/1/2007
 
First Published:
2/21/2003
2.
Phase III Randomized Study of Induction Chemotherapy Followed By Radiotherapy With or Without Efaproxiral in Patients With Stage IIIA or IIIB Non-Small Cell Lung Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
18 and over
Pharmaceutical / Industry
ALLOS-RSR13RT-013ELITE
NCT00055887
3.
Standard Whole Brain Radiation Therapy With Supplemental Oxygen, With or Without Concurrent RSR13 (Efaproxiral), in Women With Brain Metastases From Breast Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Completed
18 and over
Pharmaceutical / Industry
ENRICH Study
Brain Metastases, Breast Cancer, NCT00083304
Last Modified:
2/15/2007
 
First Published:
6/1/2000
4.
Phase I/II Study of Efaproxiral and Carmustine in Patients With Progressive or Recurrent High-Grade Gliomas
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II, Phase I
Treatment
Completed
18 and over
NCI
NABTT-9806
JHOC-NABTT-9806, NCT00005855
Last Modified:
9/20/2005
 
First Published:
3/1/1998
5.
Phase II Study of RSR13 in Patients Receiving Cranial Radiation Therapy for Glioblastoma Multiforme
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
18 and over
Pharmaceutical / Industry
NABTT-9707
ALLOS-RSR13RT-007, JHOC-NABTT-9707
Last Modified:
4/20/2007
 
First Published:
11/1/1999
6.
Phase II Study of RSR-13 in Patients With Primary Breast, Non-Small Cell Lung, Genitourinary, or Gastrointestinal Carcinoma or Melanoma Receiving Standard Cranial Radiotherapy for Brain Metastases (Summary Last Modified 04/2002)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
18 and over
NCI, Pharmaceutical / Industry
UCLA-9711049
ALLOS-RSR13RT-008, NCI-G99-1611
Last Modified:
11/8/2007
 
First Published:
1/1/2000
7.
Phase II Study of Induction Chemotherapy With Paclitaxel and Carboplatin Followed By Radiotherapy Plus RSR13 in Patients With Locally Advanced Unresectable Non-Small Cell Lung Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
18 and over
Pharmaceutical / Industry
ALLOS-RSR13RT-010
VU-VCC-THO-9828, NCT00004202
Last Modified:
9/21/2005
8.
Phase IB Study to Evaluate the Safety and Tolerance of Repetitive Daily Intravenous Doses of RSR-13 Administered to Patients Receiving Cranial Radiation Therapy for Glioblastoma Multiforme
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Completed
18 and over
Pharmaceutical / Industry
NABTT-9606
JHOC-NABTT-9606, NCI-T96-0085
Select All on One Page
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute